-
Mashup Score: 2Atrial fibrillation in Ebstein anomaly: weathering the storm - 2 year(s) ago
Ebstein anomaly (EA), a form of congenital heart disease (CHD) that occurs in 1 to 20ā000 live births, consists of a distinctive malformation of the right ventricle and tricuspid valve with adherence of septal and posterior leaflets to the underlying myocardium due to failure of embryological delamination. The consequent right atrial enlargement combined with the high prevalence of accessory…
Source: HeartCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Atrial fibrillation in Ebstein anomaly: weathering the storm - 2 year(s) ago
Ebstein anomaly (EA), a form of congenital heart disease (CHD) that occurs in 1 to 20ā000 live births, consists of a distinctive malformation of the right ventricle and tricuspid valve with adherence of septal and posterior leaflets to the underlying myocardium due to failure of embryological delamination. The consequent right atrial enlargement combined with the high prevalence of accessory…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes - 2 year(s) ago
Objective Beta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfunction (LVSD). Methods A nationwide cohort study was conducted including 43ā618 patients with MI between 2005 and 2016 in the Swedish register for…
Source: HeartCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes - 2 year(s) ago
Objective Beta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfunction (LVSD). Methods A nationwide cohort study was conducted including 43ā618 patients with MI between 2005 and 2016 in the Swedish register for…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease - 2 year(s) ago
Background The prevalence of anaemia and iron deficiency and their prognostic association with cardiovascular disease have rarely been explored at population level. Methods National Health Service records of the Greater Glasgow region for patients aged ā„50 years with a broad range of cardiovascular diagnoses were obtained. During 2013/14, prevalent disease was identified and results of…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Formal consensus study on surgery to replace the aortic valve in adults aged 18ā60 years - 2 year(s) ago
Objective There is uncertainty about surgical procedures for adult patients aged 18ā60 years undergoing aortic valve replacement (AVR). Options include conventional AVR (mechanical, mAVR; tissue, tAVR), the pulmonary autograft (Ross) and aortic valve neocuspidisation (Ozaki). Transcatheter treatment may be an option for selected patients. We used formal consensus methodology to make…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
Coronary artery disease is a serious condition increasingly affecting young adults.1 2 Despite recent improvements in primary prevention of cardiovascular (CV) disease in older patients, identifying younger adults at risk of events who would benefit from an intensive preventive strategy remains challenging,3 even if they carry traditional, actionable cardiovascular risk factors. The Appraisal of…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Objective Evidence on long-term costs of atrial fibrillation (AF) and associated factors is scarce. As part of the Swiss-AF prospective cohort study, we aimed to characterise AF costs and their development over time, and to assess specific patient clusters and their cost trajectories. Methods Swiss-AF enrolled 2415 patients with variable duration of AF between 2014 and 2017. Patient clusters…
Source: HeartCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Objective Evidence on long-term costs of atrial fibrillation (AF) and associated factors is scarce. As part of the Swiss-AF prospective cohort study, we aimed to characterise AF costs and their development over time, and to assess specific patient clusters and their cost trajectories. Methods Swiss-AF enrolled 2415 patients with variable duration of AF between 2014 and 2017. Patient clusters…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Lifestyle physical activity and rapid-rate non-sustained ventricular tachycardia in arrhythmogenic cardiomyopathy - 2 year(s) ago
Objective To investigate the association of accelerometer-measured lifestyle physical activity with rapid-rate non-sustained ventricular tachycardias (RR-NSVTs) in patients with arrhythmogenic cardiomyopathy (AC). Methods This multicentre, observational study enrolled 72 patients with AC, including right, left and biventricular forms of the disease, with underlying desmosomal and non-desmosomal…
Source: HeartCategories: Cardiology News and Journals, Latest HeadlinesTweet
RT @Heart_BMJ: Atrial fibrillation in Ebstein anomaly: weathering the storm šŖļø https://t.co/coFwuKGMsI https://t.co/tJS6pxILhv